"Slow VISA," a novel phenotype of vancomycin resistance, found in vitro in heterogeneous vancomycin-intermediate staphylococcus aureus strain Mu3

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 9, 2014, Pages 5024-5035

  Saito, Michie ^a   Katayama, Yuki ^a   Hishinuma, Tomomi ^a   Iwamoto, Akira ^a   Aiba, Yoshifumi ^a   Kuwahara Arai, Kyoko ^a   Cui, Longzhu ^a,c   Matsuo, Miki ^a   Aritaka, Nanae ^b   Hiramatsua, Keiichi ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY NERIMA HOSPITAL   (Japan)

^c KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HISTIDINE; LEUCINE; RNA POLYMERASE BETA SUBUNIT; SERINE; VANCOMYCIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; DNA DIRECTED RNA POLYMERASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CELL WALL; CONTROLLED STUDY; GENE SEQUENCE; IN VITRO STUDY; MICROBIAL MORPHOLOGY; MINIMUM INHIBITORY CONCENTRATION; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; REVERTANT; VANCOMYCIN INTERMEDIATE STAPHYLOCOCCUS AUREUS; BACTERIAL GENOME; DRUG EFFECTS; GENETICS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PROCEDURES; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CELL WALL; DNA-DIRECTED RNA POLYMERASES; GENOME, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MUTATION; PHENOTYPE; STAPHYLOCOCCUS AUREUS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 84906089016     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02470-13     Document Type: Article

References (41)

1. Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, Fukuchi Y, Kobayashi I. 1997. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350:1670-1673. http://dx.doi.org/10.1016/S0140-6736(97)07324-8. (Pubitemid 28036828)
2. Neoh HM, Cui L, Yuzawa H, Takeuchi F, Matsuo M, Hiramatsu K. 2008. Mutated response regulator graR is responsible for phenotypic conversion of Staphylococcus aureus from heterogeneous vancomycinintermediate resistance to vancomycin-intermediate resistance. Antimicrob. Agents Chemother. 52:45-53. http://dx.doi.org/10.1128/AAC.00534-07.
3. Matsuo M, Hishinuma T, Katayama Y, Cui L, Kapi M, Hiramatsu K. 2011. Mutation ofRNApolymerase beta subunit (rpoB) promotes hVISA-to-VISA phenotypic conversion of strain Mu3. Antimicrob. Agents Chemother. 55:4188-4195. http://dx.doi.org/10.1128/AAC.00398-11.
4. Matsuo M, Cui L, Kim J, Hiramatsu K. 2013. Comprehensive identification of mutations responsible for heterogeneous vancomycinintermediate Staphylococcus aureus (hVISA)-to-VISA conversion in laboratory-generated VISA strains from hVISA clinical strain Mu3. Antimicrob. Agents Chemother. 57:5843-583. http://dx.doi.org/10.1128/AAC.00425-13.
5. Champion MD, Gray V, Eberhard C, Kumar S. 2013. The evolutionary history of amino acid variations mediating increased resistance of S. aureus identifies reversion mutations in metabolic regulators. PLoS One 8:e56466. http://dx.doi.org/10.1371/journal.pone.0056466.
6. Howden BP, McEvoy CR, Allen DL, Chua K, Gao W, Harrison PF, Bell J, Coombs G, Bennett-Wood V, Porter JL, Robins-Browne R, Davies JK, Seemann T, Stinear TP. 2011. Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR. PLoS Pathog. 7:e1002359. http://dx.doi.org/10.1371/journal.ppat.1002359.
7. Katayama Y, Takeuchi F, Ito T, Ma XX, Ui-Mizutani Y, Kobayashi I, Hiramatsu K. 2003. Identification in methicillin-susceptible Staphylococcus hominis of an active primordial mobile genetic element for the staphylococcal cassette chromosome mec of methicillin-resistant Staphylococcus aureus. J. Bacteriol. 185:2711-2722. http://dx.doi.org/10.1128/JB.185.9.2711-2722.2003. (Pubitemid 36514582)
8. Bae T, Schneewind O. 2006. Allelic replacement in Staphylococcus aureus with inducible counter-selection. Plasmid 55:58-63. http://dx.doi.org/10.1016/j. plasmid.2005.05.005. (Pubitemid 41796953)
9. Katayama Y, Baba T, Sekine M, Fukuda M, Hiramatsu K. 2013. Betahemolysin promotes skin colonization by Staphylococcus aureus. J. Bacteriol. 195:1194-1203. http://dx.doi.org/10.1128/JB.01786-12.
10. Katayama Y, Murakami-Kuroda H, Cui L, Hiramatsu K. 2009. Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem. Antimicrob. Agents Chemother. 53:3190-3196. http://dx.doi.org/10.1128/AAC.00834- 08.
11. Hiramatsu K, Hanaki H. 1998. Glycopeptide resistance in staphylococci. Curr. Opin. Infect. Dis. 11:653-658. http://dx.doi.org/10.1097/00001432- 199812000-00002. (Pubitemid 29020872)
12. Cui L, Murakami H, Kuwahara-Arai K, Hanaki H, Hiramatsu K. 2000. Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50. Antimicrob. Agents Chemother. 44:2276-2285. http://dx.doi.org/10.1128/AAC.44.9.2276-2285. 2000. (Pubitemid 30650868)
13. Cui L, Isii T, Fukuda M, Ochiai T, Neoh HM, Camargo IL, Watanabe Y, Shoji M, Hishinuma T, Hiramatsu K. 2010. An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus. Antimicrob. Agents Chemother. 54:5222-5233. http://dx.doi.org/10.1128/AAC.00437- 10.
14. Aiba Y, Katayama Y, Hishinuma T, Murakami-Kuroda H, Cui L, Hiramatsu K. 2013. Mutation of RNA polymerase β-subunit gene promotes heterogeneous-to-homogeneous conversion of β-lactam resistance of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 57:4861-4871. http://dx.doi.org/10.1128/AAC.00720-13.
15. Gustafson JE, Berger-Bächi B, Strässle A, Wilkinson BJ. 1992. Autolysis of methicillin-resistant and -susceptible Staphylococcus aureus. Antimicrob. Agents Chemother. 36:566-572. http://dx.doi.org/10.1128/AAC.36.3. 566.
16. Cui L, Lian JQ, Neoh HM, Reyes E, Hiramatsu K. 2005. DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 49:3404-3413. http://dx.doi.org/10.1128/AAC.49.8.3404-3413.2005. (Pubitemid 41060589)
17. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-264. http://dx.doi.org/10.1093/biostatistics/4.2.249.
18. Cui X, Churchill GA. 2003. Statistical tests for differential expression in cDNA microarray experiments. Genome Biol. 4:210. http://dx.doi.org/10.1186/ gb-2003-4-4-210.
19. Cui L, Ma X, Sato K, Okuma K, Tenover FC, Mamizuka EM, Gemmell CG, Kim MN, Ploy MC, El-Solh N, Ferraz V, Hiramatsu K. 2003. Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J. Clin. Microbiol. 41:5-14. http://dx.doi.org/10.1128/JCM.41.1.5-14.2003. (Pubitemid 36098547)
20. Cui L, Neoh HM, Iwamoto A, Hiramatsu K. 2012. Coordinated phenotype switching with large-scale chromosome flip-flop inversion observed in bacteria. Proc. Natl. Acad. Sci. U. S. A. 109:E1647-E1656. http://dx.doi.org/10.1073/pnas. 1204307109.
21. Boyle-Vavra S, Challapalli M, Daum RS. 2003. Resistance to autolysis in vancomycin-selected Staphylococcus aureus isolates precedes vancomycin- intermediate resistance. Antimicrob. Agents Chemother. 47:2036-2039. http://dx.doi.org/10.1128/AAC.47.6.2036-2039.2003. (Pubitemid 36637841)
22. Hussain FM, Boyle-Vavra S, Shete PB, Daum RS. 2002. Evidence for a continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolates. J. Infect. Dis. 186:661-667. http://dx.doi.org/10. 1086/342708. (Pubitemid 34925538)
23. Koehl JL, Muthaiyan A, Jayaswal RK, Ehlert K, Labischinski H, Wilkinson BJ. 2004. Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus. Antimicrob. Agents Chemother. 48:3749-3757. http://dx.doi.org/10.1128/AAC.48.10.3749-3757. 2004. (Pubitemid 39304599)
24. Peschel A, Vuong C, Otto M, Götz F. 2000. The D-alanine residues of Staphylococcus aureus teichoic acids alter the susceptibility to vancomycin and the activity of autolytic enzymes. Antimicrob. Agents Chemother. 44:2845-2847. http://dx.doi.org/10.1128/AAC.44.10.2845-2847.2000.
25. Pfeltz RF, Singh VK, Schmidt JL, Batten MA, Baranyk CS, Nadakavukaren MJ, Jayaswal RK, Wilkinson BJ. 2000. Characterization of passageselected vancomycin-resistant Staphylococcus aureus strains of diverse parental backgrounds. Antimicrob. Agents Chemother. 44:294-303. http://dx.doi.org/10. 1128/AAC.44.2.294-303.2000. (Pubitemid 30060722)
26. Sakoulas G, Eliopoulos GM, Fowler VG, Jr, Moellering RC, Jr, Novick RP, Lucindo N, Yeaman MR, Bayer AS. 2005. Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function. Antimicrob. Agents Chemother. 49:2687-2692. http://dx.doi.org/10.1128/AAC.49.7.2687-2692. 2005. (Pubitemid 40917579)
27. Sieradzki K, Tomasz A. 1997. Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus. J. Bacteriol. 179:2557-2566. (Pubitemid 27164554)
28. Utaida S, Pfeltz RF, Jayaswal RK, Wilkinson BJ. 2006. Autolytic properties of glycopeptide-intermediate Staphylococcus aureus Mu50. Antimicrob. Agents Chemother. 50:1541-1545. http://dx.doi.org/10.1128/AAC.50.4.1541-1545. 2006.
29. Wootton M, Bennett PM, MacGowan AP, Walsh TR. 2005. Reduced expression of the atl autolysin gene and susceptibility to autolysis in clinical heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA) and GISA strains. J. Antimicrob. Chemother. 56:944-947. http://dx.doi.org/10.1093/jac/ dki289. (Pubitemid 41631923)
30. Yang SJ, Bayer AS, Mishra NN, Meehl M, Ledala N, Yeaman MR, Xiong YQ, Cheung AL. 2012. The Staphylococcus aureus two-component regulatory system, GraRS, senses and confers resistance to selected cationic antimicrobial peptides. Infect. Immun. 80:74-81. http://dx.doi.org/10.1128/IAI.05669-11.
31. Reed P, Veiga H, Jorge AM, Terrak M, Pinho MG. 2011. Monofunctional transglycosylases are not essential for Staphylococcus aureus cell wall synthesis. J. Bacteriol. 193:2549-2556. http://dx.doi.org/10.1128/JB.01474-10.
32. Yamakawa J, Aminaka M, Okuzumi K, Kobayashi H, Katayama Y, Kondo S, Nakamura A, Oguri T, Hori S, Cui L, Ito T, Jin J, Kurosawa H, Kaneko K, Hiramatsu K. 2012. Heterogeneously vancomycinintermediate Staphylococcus aureus (hVISA) emerged before the clinical introduction of vancomycin in Japan: a retrospective study. J. Infect. Chemother. 18:406-409. http://dx.doi.org/10. 1007/s10156-011-0330-2.
33. Hiramatsu K. 2001. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect. Dis. 1:147-155. http://dx.doi.org/10.1016/S1473-3099(01)00091-3. (Pubitemid 33586048)
34. Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, Tenover FC, Zervos MJ, Band JD, White E, Jarvis WR. 1999. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N. Engl. J. Med. 340:493-501.
35. Comas I, Borrell S, Roetzer A, Rose G, Malla B, Kato-Maeda M, Galagan J, Niemann S, Gagneux S. 2012. Whole-genome sequencing of rifampicin-resistant M. tuberculosis strains identifies compensatory mutations inRNApolymerase genes. Nat. Genet. 44:106-110. http://dx.doi.org/10.1038/ng.1038.
36. Reynolds MG. 2000. Compensatory evolution in rifampin-resistant Escherichia coli. Genetics 156:1471-1481. (Pubitemid 32001218)
37. Brandis G, Wrande M, Liljas L, Hughes D. 2012. Fitness-compensatory mutations in rifampicin-resistant RNA polymerase. Mol. Microbiol. 85: 142-151. http://dx.doi.org/10.1111/j.1365-2958.2012.08099.x.
38. D'Elia MA, Pereira MP, Chung YS, Zhao W, Chau A, Kenney TJ, Sulavik MC, Black TA, Brown ED. 2006. Lesions in teichoic acid biosynthesis in Staphylococcus aureus lead to a lethal gain of function in the otherwise dispensable pathway. J. Bacteriol. 188:4183-4189. http://dx.doi.org/10.1128/JB. 00197-06. (Pubitemid 43865737)
39. Kawai Y, Marles-Wright J, Cleverley RM, Emmins R, Ishikawa S, Kuwano M, Heinz N, Bui NK, Hoyland CN, Ogasawara N, Lewis RJ, Vollmer W, Daniel RA, Errington J. 2011. A widespread family of bacterial cell wall assembly proteins. EMBO J. 30:4931-4941. http://dx.doi.org/10.1038/emboj.2011.358.
40. Biswas R, Martinez RE, Göhring N, Schlag M, Josten M, Xia G, Hegler F, Gekeler C, Gleske AK, Götz F, Sahl HG, Kappler A, Peschel A. 2012. Proton-binding capacity of Staphylococcus aureus wall teichoic acid and its role in controlling autolysin activity. PLoS One 7:e41415. http://dx.doi.org/10. 1371/journal.pone.0041415.
41. Kuwahara-Arai K, Kondo N, Hori S, Tateda-Suzuki E, Hiramatsu K. 1996. Suppression of methicillin resistance in a mecA-containing premethicillin- resistant Staphylococcus aureus strain is caused by the mecI-mediated repression of PBP 2′ production. Antimicrob. Agents Chemother. 40:2680-2685. (Pubitemid 26404325) Technology